Reata Pharmaceuticals
RETA
$172.36
Share price
0.00%
Change (1 day)
373.78%
Change (1 year)
Categories
Reata Pharmaceuticals (RETA) - Cash on Hand
Cash on Hand as of June 2023 : $0.33 B
According to Reata Pharmaceuticals
's latest financial reports the company has $0.33 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Reata Pharmaceuticals - Cash on Hand chart (from 2014 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.38 B | -34.35% |
| 2021-12-31 | $0.59 B | -27.85% |
| 2020-12-31 | $0.81 B | 23.16% |
| 2019-12-31 | $0.66 B | 96.67% |
| 2018-12-31 | $0.33 B | 160.28% |
| 2017-12-31 | $0.12 B | 53.17% |
| 2016-12-31 | $84.73 M | 101.7% |
| 2015-12-31 | $42 M | -52.13% |
| 2014-12-31 | $87.75 M | -50.29% |
| 2013-12-31 | $0.17 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -36.95% | 🇺🇸 USA |